William P. Sheridan
Overview
William P. Sheridan received an average of $1M in total compensation, including $430K in salary, at BioCryst Pharmaceuticals from 2008 to 2021.
2021BioCryst PharmaceuticalsChief Medical Officer
2020BioCryst PharmaceuticalsChief Medical Officer
2019BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
2018BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
2017BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
2016BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
2015BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
2014BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
2013BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
2012BioCryst PharmaceuticalsSenior Vice President and Chief Medical Officer
Source: SEC filings on April 25, 2022, March 31, 2020, April 17, 2019, May 10, 2018, April 12, 2017, April 11, 2016, April 10, 2015, March 21, 2014, April 15, 2013, April 9, 2012, and April 5, 2011.
Related executives
We found 16 more executives who work or worked at BioCryst Pharmaceuticals.
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
Helen Thackray
BioCryst Pharmaceuticals
Chief R&D Officer
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
Yarlagadda Babu
BioCryst Pharmaceuticals
Chief Discovery Officer
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
Alane Barnes
BioCryst Pharmaceuticals